Hepatic artery injection of yttrium-90-lipiodol: Biodistribution in rats with hepatoma

Journal of Nuclear Medicine

Volumn 37, Issue 2, 1996, Pages 332-335

  Wang, Shyh Jen ^a   Lin, Wan Yu ^b   Lui, Wing Yiu ^b   Chen, Min Nan ^b   Tsai, Zei Tsan ^b   Ting, Gann ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

hepatic cancer; lipiodol; transarterial internal radiation therapy; yttrium 90

Indexed keywords

IODINATED POPPYSEED OIL; TRACER; YTTRIUM 90;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; DOSE RESPONSE; DRUG DISTRIBUTION; HEPATIC ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

ANIMALS; HEPATIC ARTERY; INJECTIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS, EXPERIMENTAL; MALE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; YTTRIUM RADIOISOTOPES;

EID: 0030005982     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Nakakuma K, Tashiro S, Hiraoka K, et al. Hepatocellular carcinoma and metastatic cancer detected by iodized oil. Radiology 1985,154:15-17.
2. Yumoto Y, Jinno K, Tokuyama K, et al. Hepatocellular carcinoma detected by iodized oil. Radiology 1985,154.19-24
3. 131I-ethtodol on a patient with hepatocellular carcinoma Clin Nucl Med 1986,11:514-517.
4. Kanematsu T, Furata T, Takenaka K et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989;10-98-102.
5. Kobayashi H, Hidaka Y, Tanque P, et al Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution Acta Radiol Diagn 1986;27:139-147.
6. 131I-labeled iodized oil in malignant hepatoma J Radiol 1986;67:797-801
7. 131I-labeled lipiodol. I. Radiology 1988,168.547-550.
8. Madsen MT, Park CH, Thakur ML Dosimetry of iodine-131-ethiodol in the treatment of hepatoma. J Nucl Med 1988;29:1033-1044.
9. Farnsworth APH, Vaughan ATM The influence of free DTPA on the dose distribution of yttrium-90 radiolabeled antibodies. Int J Rad Appl Instrum 1988;499-504.
10. Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90-microspheres: a phase I and II study Br J Cancer 1994,70:994-999.
11. Yan ZP, Lin G, Zhao HY, Dong YH. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer Cancer 1993,72 3210-3215.
12. Wollner I, Knutsen C, Smith P, et al. Effects of hepatic arterial yttrium-90 glass microspheres in dogs. Cancer 1988,61:1336-1344.
13. Chen MN, Wang SJ, Kao CH, Tsai ZT. A column method for lipiodol labeling with yttrium-90 [Abstract]. J Nucl Med 1994;35(suppl):241P.
14. Siegel JA. Stabin MG Absorbed fractions for electrons and beta particles in spheres of various sizes J Nucl Med 1994;35.152-156.
15. Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil, use of anticancer agents. Radiology 1985;154 25-29.
16. Ngan H Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? Br J Radiol 1990;63:771-775.
17. Maki S, Konno T, Maeda H Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 1985;56:751-777.
18. Park C, Choi SI, Kim H, et al. Distribution of lipiodol in hepatocellular carcinoma. Liver 1990;10:72-78.
19. Iwai K, Maeda H, Konno T Use of oily contrast medium for selective drug targeting to tumor:enhanced therapeutic effect and x-ray image. Cancer Res 1984;44:2115-2121.
20. Kobayashi H, Inoue H, Shimada J, et al. Intra-arterial injection of adnamycin/ mitomycin C lipiodol suspension in liver metastases. Acta Radiol 1987;28:275-280
21. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954,30:969-977
22. Kan Z, Ivancev K, Hagerstrand I, Chuang V, Lunderquist A. in vivo microscopy of the liver after injection of lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol 1989;30:419-425.
23. Okuda K, Musha H, Yamasaki T, et al Angiographic demonstration of intrahepatic arterioportal anastomoses in hepatocellular carcinoma. Radiology 1977;122:53-58.
24. Bledin AG, Kantarjian HM, Kim EE, et al. Technetium-99m-labeled macroaggregated albumin in intrahepatic arterial chemotherapy AJR 1982,139:711-715.
25. Ganong WF. Review of medical physiology, 11th ed Los Altos, CA: Lange Medical Publications; 1983.530
26. 131I-labeled lipiodol. part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988;168 541-555.
27. Maraveyas A, Snllk D, Hird V, et al Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmuno-conjugate for intrapentoneal radioimmunotherapy of ovarian cancer. Cancer 1994,73:1067-1075.
28. DeNardo GL, Kroger LA, DeNardo SJ, et al. Comparative toxicity studies of yttrium-90-MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer 1994,73:1012-1022.
29. Bayouth JE, Macey DJ. Dosimetry consideration of bone-seeking radionuclides for marrow ablation. Med Phys 1993;20 1089-1096.
30. 32P-chromic phosphate for the prevention of postoperative liver metastases in high risk colorectal cancer patients. Radiology 1983;148:555-559.
31. Turner JH, Martindale AA, Sorby P, et al Samarium-153-EDTMP therapy of disseminated skeletal metastasis. Eur J Nucl Med 1989;15:784-795
32. Turner JH, Claringbold PG, Hetherington EL, et al. A phase I study of samarium-153-ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases J Clin Oncol 1989;7:1926-1931.